John Clegg, Ph.D. - Publications

Affiliations: 
2018 Sociology New York University, New York, NY, United States 
 2018- History University of Chicago, Chicago, IL 
Area:
Capitalism, slavery, mass incarceration

0/37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches
2021 Wang LL, Janes ME, Kumbhojkar N, Kapate N, Clegg JR, Prakash S, Heavey MK, Zhao Z, Anselmo AC, Mitragotri S. Cell therapies in the clinic. Bioengineering & Translational Medicine. 6: e10214. PMID 34027097 DOI: 10.1002/btm2.10214  0.01
2021 Kapate N, Clegg JR, Mitragotri S. Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years. Advanced Drug Delivery Reviews. PMID 34023331 DOI: 10.1016/j.addr.2021.05.017  0.01
2020 Venkataraman AK, Clegg JR, Peppas NA. Polymer Composition Primarily Determines the Protein Recognition Characteristics of Molecularly Imprinted Hydrogels. Journal of Materials Chemistry. B. 8: 7685-7695. PMID 33456778 DOI: 10.1039/D0Tb01627F  0.01
2020 Clegg JR, Sun JA, Gu J, Venkataraman AK, Peppas NA. Peptide conjugation enhances the cellular co-localization, but not endosomal escape, of modular poly(acrylamide-co-methacrylic acid) nanogels. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33127451 DOI: 10.1016/j.jconrel.2020.10.045  0.01
2020 Mandal A, Clegg JR, Anselmo AC, Mitragotri S. Hydrogels in the clinic. Bioengineering & Translational Medicine. 5: e10158. PMID 32440563 DOI: 10.1002/btm2.10158  0.01
2020 Gu J, Clegg JR, Heersema LA, Peppas NA, Smyth HDC. Optimization of Cationic Nanogel PEGylation to Achieve Mammalian Cytocompatibility with Limited Loss of Gram-negative Bactericidal Activity. Biomacromolecules. PMID 32207917 DOI: 10.1021/Acs.Biomac.0C00081  0.01
2020 Clegg JR, Peppas NA. Molecular recognition with soft biomaterials. Soft Matter. PMID 31932836 DOI: 10.1039/C9Sm01981B  0.01
2019 Clegg JR, Wagner AM, Shin SR, Hassan S, Khademhosseini A, Peppas NA. Modular Fabrication of Intelligent Material-Tissue Interfaces for Bioinspired and Biomimetic Devices. Progress in Materials Science. 106. PMID 32189815 DOI: 10.1016/J.Pmatsci.2019.100589  0.01
2019 Clegg JR, Irani AS, Ander EW, Ludolph CM, Venkataraman AK, Zhong JX, Peppas NA. Synthetic networks with tunable responsiveness, biodegradation, and molecular recognition for precision medicine applications. Science Advances. 5: eaax7946. PMID 31598554 DOI: 10.1126/Sciadv.Aax7946  0.01
2019 Clegg J, Foley D. A classical-Marxian model of antebellum slavery Cambridge Journal of Economics. 43: 107-138. DOI: 10.1093/Cje/Bex075  0.01
2018 Culver HR, Clegg JR, Peppas NA. Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery. Accounts of Chemical Research. PMID 30204406 DOI: 10.1021/Acs.Accounts.8B00411  0.01
2018 Zhong JX, Clegg JR, Ander EW, Peppas NA. Tunable Poly((methacrylic acid)-co-acrylamide) Nanoparticles through Inverse Emulsion Polymerization. Journal of Biomedical Materials Research. Part A. PMID 29453807 DOI: 10.1002/Jbm.A.36371  0.01
2017 Clegg JR, Wechsler ME, Peppas NA. Vision for Functionally Decorated and Molecularly Imprinted Polymers in Regenerative Engineering. Regenerative Engineering and Translational Medicine. 3: 166-175. PMID 30906848 DOI: 10.1007/s40883-017-0028-9  0.01
2017 Clegg JR, Zhong JX, Irani AS, Gu J, Spencer DS, Peppas NA. Characterization of protein interactions with molecularly imprinted hydrogels that possess engineered affinity for high isoelectric point biomarkers. Journal of Biomedical Materials Research. Part A. PMID 28177574 DOI: 10.1002/Jbm.A.36029  0.01
2017 Culver HR, Clegg JR, Peppas NA. Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery. Accounts of Chemical Research. PMID 28170227 DOI: 10.1021/Acs.Accounts.6B00533  0.01
2016 Peppas NA, Clegg JR. The challenge to improve the response of biomaterials to the physiological environment. Regenerative Biomaterials. 3: 67-71. PMID 27047671 DOI: 10.1093/Rb/Rbw012  0.01
2016 Clegg J. A Class Blind Spot? Anti-racism in the United States Global Labour Journal. 7. DOI: 10.15173/Glj.V7I3.3030  0.01
2014 Beaudet A, Clegg J, Thuresson PO, Lloyd A, McEwan P. Review of utility values for economic modeling in type 2 diabetes. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: 462-70. PMID 24969008 DOI: 10.1016/j.jval.2014.03.003  0.01
2013 Fonseca T, Clegg J, Caputo G, Norrbacka K, Dilla T, Alvarez M. The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m(2) in Spain. Journal of Medical Economics. 16: 926-38. PMID 23659201 DOI: 10.3111/13696998.2013.803110  0.01
2012 Guerreiro JF, Meyer D, Diniz IG, Santos AR, Santos EJ, Clegg JB. β-Globin polymorphisms in Amerindian populations from the Brazilian Amazon. American Journal of Human Biology : the Official Journal of the Human Biology Council. 24: 432-5. PMID 22323332 DOI: 10.1002/Ajhb.22235  0.01
2010 Pountos I, Clegg J, Siddiqui A. Diagnosis and treatment of greenstick and torus fractures of the distal radius in children: a prospective randomised single blind study. Journal of Children's Orthopaedics. 4: 321-6. PMID 21804894 DOI: 10.1007/s11832-010-0269-3  0.01
2010 O'Riordan S, Hien TT, Miles K, Allen A, Quyen NN, Hung NQ, Anh do Q, Tuyen LN, Khoa DB, Thai CQ, Triet DM, Phu NH, Dunstan S, Peto T, Clegg J, et al. Large scale screening for haemoglobin disorders in southern Vietnam: implications for avoidance and management. British Journal of Haematology. 150: 359-64. PMID 20497177 DOI: 10.1111/j.1365-2141.2010.08237.x  0.01
2008 Guest JF, Clegg JP, Helter MT. Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK. Current Medical Research and Opinion. 24: 1841-52. PMID 18558017 DOI: 10.1185/03007990802102349  0.01
2007 Guest JF, Candy DCA, Clegg JP, Edwards D, Helter MT, Dale AK, Fell J, Cosgrove M, Debelle G. Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales Current Medical Research and Opinion. 23: 2213-2225. PMID 17692152 DOI: 10.1185/030079907X210462  0.01
2007 Clegg JP, Guest JF, Hurskainen R. Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Current Medical Research and Opinion. 23: 1637-48. PMID 17559758 DOI: 10.1185/030079907x199709  0.01
2007 O'Donnell A, Raiko A, Clegg JB, Weatherall DJ, Allen SJ. Southeast Asian ovalocytosis and pregnancy in a malaria-endemic region of Papua New Guinea. The American Journal of Tropical Medicine and Hygiene. 76: 631-3. PMID 17426161  0.01
2007 Clegg JP, Guest JF. Modelling the cost-utility of bio-electric stimulation therapy compared to standard care in the treatment of elderly patients with chronic non-healing wounds in the UK. Current Medical Research and Opinion. 23: 871-83. PMID 17407644 DOI: 10.1185/030079906x167705  0.01
2006 Guest JF, Clegg JP, Smith AF. Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK. Current Medical Research and Opinion. 22: 1777-85. PMID 16968581 DOI: 10.1185/030079906X115739  0.01
2006 Clegg JP, Guest JF, Lehman A, Smith AF. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiology. 13: 263-74. PMID 16877285 DOI: 10.1080/09286580600801044  0.01
2006 Guest JF, Clegg JP. Modelling the costs and consequences of treating paediatric faecal impaction in Australia. Current Medical Research and Opinion. 22: 107-19. PMID 16393437 DOI: 10.1185/030079905X65583  0.01
2005 Guest JF, Davie AM, Clegg JP. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK. Current Medical Research and Opinion. 21: 817-26. PMID 15969881 DOI: 10.1185/030079905X41471  0.01
2005 Guest JF, Clegg JP, Davie AM, McCloskey E. Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK. Current Medical Research and Opinion. 21: 805-15. PMID 15969880 DOI: 10.1185/030079905X40472  0.01
2003 Webster MT, Clegg JB, Harding RM. Common 5′ β-globin RFLP haplotypes harbour a surprising level of ancestral sequence mosaicism Human Genetics. 113: 123-139. PMID 12736816  0.01
2002 Bache CE, Clegg J, Herron M. Risk factors for developmental dysplasia of the hip: ultrasonographic findings in the neonatal period. Journal of Pediatric Orthopedics. Part B. 11: 212-8. PMID 12089497  0.01
2002 Webster MT, Wells RS, Clegg JB. Analysis of variation in the human beta-globin gene cluster using a novel DHPLC technique. Mutation Research. 501: 99-103. PMID 11934441 DOI: 10.1016/S0027-5107(02)00017-9  0.01
2002 Schneider JA, Peto TE, Boone RA, Boyce AJ, Clegg JB. Direct measurement of the male recombination fraction in the human beta-globin hot spot. Human Molecular Genetics. 11: 207-15. PMID 11823440  0.01
2002 Currat M, Trabuchet G, Rees D, Perrin P, Harding RM, Clegg JB, Langaney A, Excoffier L. Molecular analysis of the beta-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the beta(S) Senegal mutation. American Journal of Human Genetics. 70: 207-23. PMID 11741197 DOI: 10.1086/338304  0.01
Hide low-probability matches.